SKIN-CANCER-PROBE · A novel handheld probe coupled to mass spectrometer as a non-invasive tool for fast in vivo diagnosis of skin cancer
Horizon 2020 — Marie Skłodowska-Curie Actions
- Duration
- 2020-08-01 → 2023-04-02
- EU contribution
- €145,356
- Participants
- 1
- Scheme
- MSCA-IF
Lines connect the coordinator with its partners.
Results in brief
A novel handheld probe coupled to mass spectrometer as a non-invasive tool for fast in vivo diagnosis of skin cancer
This project describes a sampler probe that can be used for sampling from the skin surface and can be coupled on-line with mass spectrometry for fast diagnosis of skin cancer. The probe is a handheld pen-like device with extractive phase coated rotating tip. The coated tip is selective for extraction of small molecules and can monitor the chemical differences present on the tissue. The working principle of the probe is based on exposure of the extractive tip of the probe for a certain time to the tissue surface and sequential analysis of the extract enriched with molecules in on-line mode with highly selective and sensitive electrospray ionization mass spectrometry (ESI-MS). In this study, the probe has been successfully used in vivo for detection of differentiating metabolites in mice with skin cancer.
Data: CORDIS, © European Union
Project objective
Ambient mass spectrometry (AMS) has gained substantial attention in numerous research fields including clinical diagnosis as being anondestructive, fast and simple approach. Despite of the advances in mass spectrometry (MS) one of its main disadvantages is the simultaneous introduction of the matrix and analyte to MS that results in low sensitivity associated with a high background and ion suppression, and frequent instrumental maintenance. Therefore, there is a need for a ground-breaking sampling tool that is combinable with MS and that does not compromise the above mentioned merits.Here we propose (i) to develop a novel handheld probe, which will have micro extraction mechanism for small molecules/biomarkers from the surface and can be combined with MS for real time targeted and untargeted analyses; (ii) to utilize the probe as a clinical diagnostic tool for noninvasive fast determination of skin cancer. The probe will be designed as a surface touch sampling device suitable for spot analysis and for continuous mode chemical imaging of surface. The device will be integrated with online desorption using a solvent junction and desorbed metabolites will be directed to MS. As proof-of-concept, skin cancer biomarkers and some other typical skin metabolites will be targeted during the probe development. Preliminary analyses with the probe will be conducted on the surface of agarose gel spiked with the selected metabolites mimicking artificial skin surface using MS in targeted mode. Upon development of the probe and prove of the detection of the biomarkers from the synthetic skin media the study will be extended to in vivo mice model with tumor. This novel probe will make a significant impact as rapid and reliable diagnostic tool. This project will open an opportunity for the researcher to develop her future career by implementing the novel probe in emerging research fields (e.g. clinical, forensic, etc.), where fast and reliable analytical tools are in high demand.
Original text from CORDIS.
Participants
- MIDDLE EAST TECHNICAL UNIVERSITY · AnkaraCoordinatorTürkiye
Links
Data: CORDIS, © European Union